Understanding the potential and limitations of new Acinetobacter baumannii active therapies.
Jacob Snowdin, DO
Advertisement
Snowdin is a second-year (PGY5) infectious disease fellow at Maine Medical Center in Portland. He is a member of the Infectious Diseases Society of America.
Articles by Jacob Snowdin, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Dynavax and Vaxart Partner to Advance Oral COVID-19 Vaccine
2
Using Doxycycline for Post-Exposure Prevention of Lyme Disease in Young Kids
3
Penicillin-Binding Proteins Reconsidered: A Clinician's Guide from Targets to Dynamic Cell-Wall Control
4
